Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of apolipoprotein B and excess apolipoprotein B with cardiovascular risk in type 2 diabetes: a prospective cohort study of the UK Biobank.

Lipids in health and disease·2026
Same author

Signatures of proteomics and glycoproteomics revealed liraglutide ameliorates MASLD by regulating specific metabolic homeostasis in mice.

Journal of pharmaceutical analysis·2025
Same author

CXCR4 Clustering Induced by Polymeric Nanothreads Impedes Cancer Cell Metastasis via PIEZO1-Mediated Mechanotransduction.

Advanced healthcare materials·2025
Same author

Enhance Efferocytosis and Block the Macrophages-Platelets Feedback Loop for Targeted Treatment of Psoriasis.

ACS nano·2025
Same author

Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition.

Nature communications·2024
Same author

A nano-platform combats the "attack" and "defense" of cytoskeleton to block cascading tumor metastasis.

Journal of controlled release : official journal of the Controlled Release Society·2024

Related Experiment Video

Updated: Sep 23, 2025

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

1.1K

Split bullets loaded nanoparticles for amplified immunotherapy.

Chendong Liu1, Lian Li1, Jiayan Lyu1

  • 1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug, Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|May 13, 2022
PubMed
Summary

This study introduces a novel nanoplatform that dual-targets tumor cell mitochondria and endoplasmic reticulum. This approach enhances dendritic cell (DC) function, boosting antitumor immunity and establishing long-term immune memory.

Keywords:
Dendritic cellEndoplasmic reticulumImmunotherapyMitochondriaNanoparticle

More Related Videos

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.7K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

Related Experiment Videos

Last Updated: Sep 23, 2025

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

1.1K
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.7K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K

Area of Science:

  • Immunology
  • Nanotechnology
  • Cancer Therapy

Background:

  • Dendritic cells (DCs) are crucial for adaptive antitumor immunity.
  • Tumor microenvironments often suppress DC function, limiting therapeutic efficacy.
  • Existing immunotherapies face challenges due to low tumor immunogenicity.

Purpose of the Study:

  • To develop a nanoplatform capable of dual subcellular targeting within tumor cells.
  • To enhance dendritic cell recruitment and activation for improved antitumor responses.
  • To establish a generalizable strategy for augmenting cancer immunotherapy.

Main Methods:

  • Development of a "split bullets" loaded nanoplatform.
  • Mitochondria (MT)-targeted component triggers ATP release, recruiting peripheral DCs.
  • Endoplasmic reticulum (ER)-targeted component activates tumor-infiltrating DCs via calreticulin exposure.

Main Results:

  • The nanoplatform effectively targets both mitochondria and endoplasmic reticulum in tumor cells.
  • Dual targeting enhances DC tropism and reactivity to tumor-specific antigens.
  • Treatment suppressed primary melanoma and established systemic immune memory against recurrence.

Conclusions:

  • The developed nanoplatform offers a novel strategy to enhance dendritic cell function.
  • This approach shows promise in boosting antitumor immunity and overcoming treatment resistance.
  • The nanoplatform provides a generalizable method for improving cancer immunotherapy outcomes.